Sign In
Buy DEI
Douglas Emmett Earnings Calls
| Release date | May 05, 2026 |
| EPS estimate | -$0.0468 |
| EPS actual | $0.370 |
| EPS Surprise | 890.26% |
| Revenue estimate | 251.111M |
| Revenue actual | 250.959M |
| Revenue Surprise | -0.0605% |
| Release date | Feb 10, 2026 |
| EPS estimate | -$0.0547 |
| EPS actual | $0.350 |
| EPS Surprise | 739.97% |
| Revenue estimate | 252.262M |
| Revenue actual | 249.433M |
| Revenue Surprise | -1.12% |
| Release date | Nov 04, 2025 |
| EPS estimate | $0.340 |
| EPS actual | $0.340 |
| Revenue estimate | 252.791M |
| Revenue actual | 250.58M |
| Revenue Surprise | -0.87% |
| Release date | Aug 05, 2025 |
| EPS estimate | $0.370 |
| EPS actual | $0.370 |
| Revenue estimate | 257.261M |
| Revenue actual | 252.434M |
| Revenue Surprise | -1.88% |
Last 4 Quarters for Douglas Emmett
Below you can see how DEI performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 05, 2025 |
| Price on release | $15.12 |
| EPS estimate | $0.370 |
| EPS actual | $0.370 |
| Date | Price |
|---|---|
| Jul 30, 2025 | $15.39 |
| Jul 31, 2025 | $15.16 |
| Aug 01, 2025 | $14.91 |
| Aug 04, 2025 | $14.82 |
| Aug 05, 2025 | $15.12 |
| Aug 06, 2025 | $14.68 |
| Aug 07, 2025 | $14.52 |
| Aug 08, 2025 | $14.43 |
| Aug 11, 2025 | $14.06 |
| 4 days before | -1.75% |
| 4 days after | -7.01% |
| On release day | -2.91% |
| Change in period | -8.64% |
| Release date | Nov 04, 2025 |
| Price on release | $12.84 |
| EPS estimate | $0.340 |
| EPS actual | $0.340 |
| Date | Price |
|---|---|
| Oct 29, 2025 | $12.69 |
| Oct 30, 2025 | $12.73 |
| Oct 31, 2025 | $12.94 |
| Nov 03, 2025 | $12.96 |
| Nov 04, 2025 | $12.84 |
| Nov 05, 2025 | $12.23 |
| Nov 06, 2025 | $11.97 |
| Nov 07, 2025 | $12.41 |
| Nov 10, 2025 | $12.20 |
| 4 days before | 1.18% |
| 4 days after | -5.02% |
| On release day | -4.75% |
| Change in period | -3.90% |
| Release date | Feb 10, 2026 |
| Price on release | $10.61 |
| EPS estimate | -$0.0547 |
| EPS actual | $0.350 |
| EPS surprise | 739.97% |
| Date | Price |
|---|---|
| Feb 04, 2026 | $10.48 |
| Feb 05, 2026 | $10.46 |
| Feb 06, 2026 | $10.59 |
| Feb 09, 2026 | $10.55 |
| Feb 10, 2026 | $10.61 |
| Feb 11, 2026 | $10.27 |
| Feb 12, 2026 | $9.88 |
| Feb 13, 2026 | $10.11 |
| Feb 17, 2026 | $9.97 |
| 4 days before | 1.24% |
| 4 days after | -6.03% |
| On release day | -3.20% |
| Change in period | -4.87% |
| Release date | May 05, 2026 |
| Price on release | $11.33 |
| EPS estimate | -$0.0468 |
| EPS actual | $0.370 |
| EPS surprise | 890.26% |
| Date | Price |
|---|---|
| Apr 29, 2026 | $10.76 |
| Apr 30, 2026 | $10.81 |
| May 01, 2026 | $10.94 |
| May 04, 2026 | $11.09 |
| May 05, 2026 | $11.33 |
| May 06, 2026 | $12.17 |
| May 07, 2026 | $12.04 |
| May 08, 2026 | $12.37 |
| May 11, 2026 | $12.13 |
| 4 days before | 5.30% |
| 4 days after | 7.06% |
| On release day | 7.41% |
| Change in period | 12.73% |
Douglas Emmett Earnings Call Transcript Summary of Q1 2026
Douglas Emmett reported a strong quarter driven by leasing momentum and strategic acquisitions. Key operating highlights: ~100k sq ft of positive absorption for a second consecutive quarter, a quarterly record of ~461k sq ft of new leases and 218 leases totaling 909k sq ft, particularly strong demand from tenants >10k sq ft across multiple industries, and residential same-property NOI up 4.2% with >99% leased. Management completed two acquisitions including the Bedford medical-office portfolio in Beverly Hills (Douglas Emmett holds a 13% JV equity stake) and is progressing three redevelopment projects (Landmark Residences, 10900 Wilshire conversion, and Studio Plaza). Financially, revenue was roughly flat at $251M, FFO decreased to $0.37 per share and AFFO fell to $49M due to higher interest expense and lower interest income; same-property cash NOI declined 1.4%. Guidance: 2026 diluted net income per share expected between -$0.20 and -$0.14; fully diluted FFO per share expected between $1.39 and $1.45. Management remains cautiously optimistic about a potential bottom in the office cycle, is focused on growing earnings through leasing, acquisitions, and redevelopments, and is securing favorable debt terms (including fixing financing rates on recent deals).
